1. Home
  2. LEXX vs SOND Comparison

LEXX vs SOND Comparison

Compare LEXX & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • SOND
  • Stock Information
  • Founded
  • LEXX 2004
  • SOND 2014
  • Country
  • LEXX Canada
  • SOND United States
  • Employees
  • LEXX N/A
  • SOND N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • SOND Hotels/Resorts
  • Sector
  • LEXX Health Care
  • SOND Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • SOND Nasdaq
  • Market Cap
  • LEXX 19.6M
  • SOND 23.2M
  • IPO Year
  • LEXX N/A
  • SOND N/A
  • Fundamental
  • Price
  • LEXX $0.89
  • SOND $2.79
  • Analyst Decision
  • LEXX Strong Buy
  • SOND
  • Analyst Count
  • LEXX 1
  • SOND 0
  • Target Price
  • LEXX $5.00
  • SOND N/A
  • AVG Volume (30 Days)
  • LEXX 146.9K
  • SOND 331.0K
  • Earning Date
  • LEXX 07-22-2025
  • SOND 07-15-2025
  • Dividend Yield
  • LEXX N/A
  • SOND N/A
  • EPS Growth
  • LEXX N/A
  • SOND N/A
  • EPS
  • LEXX N/A
  • SOND N/A
  • Revenue
  • LEXX $525,923.00
  • SOND $624,458,000.00
  • Revenue This Year
  • LEXX $0.62
  • SOND $28.50
  • Revenue Next Year
  • LEXX $14.19
  • SOND $17.62
  • P/E Ratio
  • LEXX N/A
  • SOND N/A
  • Revenue Growth
  • LEXX 29.95
  • SOND 8.32
  • 52 Week Low
  • LEXX $0.82
  • SOND $0.88
  • 52 Week High
  • LEXX $4.38
  • SOND $10.50
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 39.71
  • SOND 61.13
  • Support Level
  • LEXX $0.86
  • SOND $2.69
  • Resistance Level
  • LEXX $1.05
  • SOND $3.44
  • Average True Range (ATR)
  • LEXX 0.06
  • SOND 0.31
  • MACD
  • LEXX 0.00
  • SOND 0.10
  • Stochastic Oscillator
  • LEXX 26.84
  • SOND 62.94

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About SOND Sonder Holdings Inc.

Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.

Share on Social Networks: